Affective and psychotic symptoms associated with anabolic steroid use



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Pope, H. G.
	Articles by Katz, D. L.
	Search for Related Content



	PubMed Citation
	Articles by Pope, H. G., Jr
	Articles by Katz, D. L.

Am J Psychiatry 1988; 145:487-490
Copyright © 1988 by American Psychiatric Association

REVIEW OF REPORTED CASES

Affective and psychotic symptoms associated with anabolic steroid use

HG Pope Jr and DL Katz
Epidemiology Laboratory, Mailman Research Center, McLean Hospital, Belmont, MA 02178.

To assess the frequency of affective and psychotic symptoms in athletes taking anabolic steroids, the authors performed structured interviews of 41 body-builders and football players who had used steroids. According to DSM-III-R, nine subjects (22%) displayed a full affective syndrome, and five (12%) displayed psychotic symptoms in association with steroid use. These findings suggest that major psychiatric symptoms may be a common adverse effect of these drugs.

This article has been cited by other articles:

C. A. A. Penatti, D. M. Porter, and L. P. Henderson
Chronic Exposure to Anabolic Androgenic Steroids Alters Neuronal Function in the Mammalian Forebrain via Androgen Receptor- and Estrogen Receptor-Mediated Mechanisms
J. Neurosci., October 7, 2009; 29(40): 12484 - 12496.
[Abstract] [Full Text] [PDF]

M Ebinger, C Sievers, D Ivan, H. Schneider, and G. Stalla
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?
J Psychopharmacol, September 1, 2009; 23(7): 841 - 853.
[Abstract] [PDF]

K. M. Beaver, M. G. Vaughn, M. DeLisi, and J. P. Wright
Anabolic-Androgenic Steroid Use and Involvement in Violent Behavior in a Nationally Representative Sample of Young Adult Males in the United States
Am J Public Health, December 1, 2008; 98(12): 2185 - 2187.
[Abstract] [Full Text] [PDF]

J. S. Perrin, P.-Y. Herve, G. Leonard, M. Perron, G. B. Pike, A. Pitiot, L. Richer, S. Veillette, Z. Pausova, and T. Paus
Growth of White Matter in the Adolescent Brain: Role of Testosterone and Androgen Receptor
J. Neurosci., September 17, 2008; 28(38): 9519 - 9524.
[Abstract] [Full Text] [PDF]

P. J. Perry
Corticosteroid- and Anabolic Steroid Induced Mental Status Disturbances
Journal of Pharmacy Practice, August 1, 2007; 20(4): 334 - 340.
[Abstract] [PDF]

H. Rashid, S. Ormerod, and E. Day
Anabolic androgenic steroids: what the psychiatrist needs to know
Adv. Psychiatr. Treat., May 1, 2007; 13(3): 203 - 211.
[Abstract] [Full Text] [PDF]

R. C. Marqueti, N. A. Parizotto, R. S. Chriguer, S. E. A. Perez, and H. S. Selistre-de-Araujo
Androgenic-Anabolic Steroids Associated With Mechanical Loading Inhibit Matrix Metallopeptidase Activity and Affect the Remodeling of the Achilles Tendon in Rats
Am. J. Sports Med., August 1, 2006; 34(8): 1274 - 1280.
[Abstract] [Full Text] [PDF]

M. Nugent and G. S. Waterman
An adrenal adenoma presenting with psychosis.
Psychosomatics, March 1, 2006; 47(2): 175 - 177.
[Full Text] [PDF]

T. S. Cunha, M. Jose, C. S. Moura, C. F. Bernardes, A. P. Tanno, and F. K. Marcondes
Vascular Sensitivity to Phenylephrine in Rats Submitted to Anaerobic Training and Nandrolone Treatment
Hypertension, October 1, 2005; 46(4): 1010 - 1015.
[Abstract] [Full Text] [PDF]

R. C.W. Hall, R. C.W. Hall, and M. J. Chapman
Psychiatric Complications of Anabolic Steroid Abuse
Psychosomatics, August 1, 2005; 46(4): 285 - 290.
[Abstract] [Full Text] [PDF]

L. Ben-Noun
Mental Disorder that Afflicted King David the Great
History of Psychiatry, December 1, 2004; 15(4): 467 - 476.
[Abstract] [PDF]

S. Nilsson, P. Allebeck, B. Marklund, A. Baigi, and B. Fridlund
Evaluation of a health promotion programme to prevent the misuse of androgenic anabolic steroids among Swedish adolescents
Health Promot. Int., March 1, 2004; 19(1): 61 - 67.
[Abstract] [Full Text] [PDF]

J. W. Williams Jr, P. H. Noel, J. A. Cordes, G. Ramirez, and M. Pignone
Is This Patient Clinically Depressed?
JAMA, March 6, 2002; 287(9): 1160 - 1170.
[Abstract] [Full Text] [PDF]

C. M. Kuhn
Anabolic Steroids
Recent Prog. Horm. Res., January 1, 2002; 57(1): 411 - 434.
[Abstract] [Full Text] [PDF]

R. C. Daly, T.-P. Su, P. J. Schmidt, D. Pickar, D. L. Murphy, and D. R. Rubinow
Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary Findings
Arch Gen Psychiatry, February 1, 2001; 58(2): 172 - 177.
[Abstract] [Full Text] [PDF]

J. C. Jorge-Rivera, K. L. McIntyre, and L. P. Henderson
Anabolic Steroids Induce Region- and Subunit-Specific Rapid Modulation of GABAA Receptor-Mediated Currents in the Rat Forebrain
J Neurophysiol, June 1, 2000; 83(6): 3299 - 3309.
[Abstract] [Full Text] [PDF]

L. Goldberg, D. P. MacKinnon, D. L. Elliot, E. L. Moe, G. Clarke, and J. Cheong
The Adolescents Training and Learning to Avoid Steroids Program: Preventing Drug Use and Promoting Health Behaviors
Arch Pediatr Adolesc Med, April 1, 2000; 154(4): 332 - 338.
[Abstract] [Full Text] [PDF]

R. Morton, O. Gleason, and W. Yates
Psychiatric Effects of Anabolic Steroids After Burn Injuries
Psychosomatics, February 1, 2000; 41(1): 66 - 68.
[Full Text]

A. J. Woodiwiss, B. Trifunovic, M. Philippides, and G. R. Norton
Effects of an androgenic steroid on exercise-induced cardiac remodeling in rats
J Appl Physiol, February 1, 2000; 88(2): 409 - 415.
[Abstract] [Full Text] [PDF]

H. G. Pope Jr, E. M. Kouri, and J. I. Hudson
Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men: A Randomized Controlled Trial
Arch Gen Psychiatry, February 1, 2000; 57(2): 133 - 140.
[Abstract] [Full Text] [PDF]

S.-f. Lu, S. E. McKenna, A. Cologer-Clifford, E. A. Nau, and N. G. Simon
Androgen Receptor in Mouse Brain: Sex Differences and Similarities in Autoregulation
Endocrinology, April 1, 1998; 139(4): 1594 - 1601.
[Abstract] [Full Text] [PDF]

M. I. Fingerhood, J. T. Sullivan, M. Testa, and D. R. Jasinski
Abuse liability of testosterone
J Psychopharmacol, January 1, 1997; 11(1): 59 - 63.
[Abstract] [PDF]

L. Goldberg, D. Elliot, G. N. Clarke, D. P. MacKinnon, E. Moe, L. Zoref, C. Green, S. L. Wolf, E. Greffrath, D. J. Miller, et al.
Effects of a Multidimensional Anabolic Steroid Prevention Intervention: The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program
JAMA, November 20, 1996; 276(19): 1555 - 1562.
[Abstract] [PDF]

L. Goldberg
Questions and Answers
JAMA, July 17, 1996; 276(3): 257 - 257.
[PDF]

L. Goldberg, D. L. Elliot, G. N. Clarke, D. P. MacKinnon, L. Zoref, E. Moe, C. Green, and S. L. Wolf
The Adolescents Training and Learning to Avoid Steroids (ATLAS) Prevention Program: Background and Results of a Model Intervention
Arch Pediatr Adolesc Med, July 1, 1996; 150(7): 713 - 721.
[Abstract] [PDF]

C. J. Bagatell and W. J. Bremner
Androgens in Men -- Uses and Abuses
N. Engl. J. Med., March 14, 1996; 334(11): 707 - 715.
[Full Text] [PDF]

H. G. Pope Jr and D. L. Katz
Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use: A Controlled Study of 160 Athletes
Arch Gen Psychiatry, May 1, 1994; 51(5): 375 - 382.
[Abstract] [PDF]

C. E. Yesalis, N. J. Kennedy, A. N. Kopstein, and M. S. Bahrke
Anabolic-Androgenic Steroid Use in the United States
JAMA, September 8, 1993; 270(10): 1217 - 1221.
[Abstract] [PDF]

T.-P. Su, M. Pagliaro, P. J. Schmidt, D. Pickar, O. Wolkowitz, and D. R. Rubinow
Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers
JAMA, June 2, 1993; 269(21): 2760 - 2764.
[Abstract] [PDF]

H. A. Haupt
Anabolic steroids and growth hormone
Am. J. Sports Med., June 1, 1993; 21(3): 468 - 474.
[PDF]

D.J. Williamson and A.H. Young
Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: a brief review of the literature
J Psychopharmacol, January 1, 1992; 6(1): 20 - 26.
[Abstract] [PDF]

G. Glazer
Atherogenic Effects of Anabolic Steroids on Serum Lipid Levels: A Literature Review
Arch Intern Med, October 1, 1991; 151(10): 1925 - 1933.
[Abstract] [PDF]

A. J. Giannini, N. Miller, and D. K. Kocjan
Treating Steroid Abuse: A Psychiatric Perspective
Clinical Pediatrics, September 1, 1991; 30(9): 538 - 542.
[PDF]

Council on Scientific Affairs
Medical and Nonmedical Uses of Anabolic-Androgenic Steroids
JAMA, December 12, 1990; 264(22): 2923 - 2927.
[Abstract] [PDF]

P. J. Perry, K. H. Andersen, and W. R. Yates
Illicit anabolic steroid use in athletes: A case series analysis
Am. J. Sports Med., July 1, 1990; 18(4): 422 - 428.
[Abstract] [PDF]

R. Terney and L. G. McLain
The Use of Anabolic Steroids in High School Students
Arch Pediatr Adolesc Med, January 1, 1990; 144(1): 99 - 103.
[Abstract] [PDF]

T.-P. SU, E. D. LONDON, and J. H. JAFFE
Response: Steroid Binding at sgr-"Opioid" Receptors
Science, December 22, 1989; 246(4937): 1637 - 1638.
[PDF]

K. B. Kashkin and H. D. Kleber
Hooked on Hormones? An Anabolic Steroid Addiction Hypothesis
JAMA, December 8, 1989; 262(22): 3166 - 3170.
[Abstract] [PDF]

Z. Amsel, S. G. Genser, and H. W. Haverkos
Anabolic Steroid Use Among Male High School Seniors
JAMA, May 12, 1989; 261(18): 2639 - 2640.
[Abstract] [PDF]

Get information about faster international access.